| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/08/2000 | CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression |
| 06/08/2000 | CA2352878A1 Antitumor dibenzofluorene derivatives |
| 06/08/2000 | CA2352555A1 Transport system conjugate |
| 06/08/2000 | CA2352539A1 Recombinant soluble fc receptors |
| 06/08/2000 | CA2352512A1 Lak activity enhancers derived from extract of lentinus endodes mycelium and lak activity-enhancers formulations containing the extract |
| 06/08/2000 | CA2352491A1 Peptides carrying substances across the blood brain barrier |
| 06/08/2000 | CA2352459A1 .gamma..delta.t cell immunoactivity enhancers containing extract of lentinus edodes mycelium |
| 06/08/2000 | CA2352367A1 Nonsteroidal antiinflammatories |
| 06/08/2000 | CA2352134A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide |
| 06/08/2000 | CA2351321A1 Hydrazine derivatives |
| 06/08/2000 | CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 06/08/2000 | CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 06/08/2000 | CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/08/2000 | CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2000 | EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 06/07/2000 | EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein |
| 06/07/2000 | EP1006194A2 C-erbB-2 external domain: GP75 |
| 06/07/2000 | EP1006186A1 Human genes |
| 06/07/2000 | EP1006184A1 IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof |
| 06/07/2000 | EP1006183A1 Recombinant soluble Fc receptors |
| 06/07/2000 | EP1006113A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth |
| 06/07/2000 | EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 06/07/2000 | EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme |
| 06/07/2000 | EP1005545A1 Human extracellular matrix-1 |
| 06/07/2000 | EP1005539A1 IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS |
| 06/07/2000 | EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 06/07/2000 | EP1005460A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 06/07/2000 | EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors |
| 06/07/2000 | EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 06/07/2000 | EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 06/07/2000 | EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 06/07/2000 | EP1005354A1 Peptide mimetics of the cytokine receptor gamma chain |
| 06/07/2000 | EP1005350A1 Composition and method of treating cancer with tannic acid and tannin complexes |
| 06/07/2000 | EP1005346A2 Solutions containing azasteroids |
| 06/07/2000 | EP1005344A1 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid x receptor selective agonists |
| 06/07/2000 | EP1005343A1 Use of csaid?tm compounds as inhibitors of angiogenesis |
| 06/07/2000 | EP0855909A4 Radiosensitizing taxanes and their pharmaceutical preparations |
| 06/07/2000 | EP0840606B1 Di- and trivalent small molecule selectin inhibitors |
| 06/07/2000 | EP0714304B1 Therapeutic system for treating psoriasis |
| 06/07/2000 | CN1255926A 20(S) camptothecin glycoconjugates |
| 06/07/2000 | CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors |
| 06/07/2000 | CN1255855A Fructan containing compsn. for prevention and treatment of colon cancer |
| 06/07/2000 | CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds |
| 06/07/2000 | CN1255379A Identification method of compound for inhibiting tumour injury and medicinal compsns. containing said compound |
| 06/07/2000 | CN1255378A Monoclonal antibody Fab'-Pingyangmycin conjugate and its anticancer action |
| 06/07/2000 | CN1255376A Method of enhancing crude drugs anti-tumour activity |
| 06/07/2000 | CN1255342A Process for preparing black nightshade extract as anticancer medicine |
| 06/07/2000 | CN1255333A Medical application of aquatic-sunflower lactone |
| 06/07/2000 | CN1053194C Process for preparing n-acyl-5-fluorocytidine derivatives |
| 06/07/2000 | CN1053117C Processes for prepn. of compsns. used in treatment of kaposi |
| 06/07/2000 | CN1053108C Chinese medicine for treating primary liver cancer |
| 06/07/2000 | CN1053103C Pharmaceutical use of 24-homo-vitamin-D-derivative |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| 06/06/2000 | US6071952 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 06/06/2000 | US6071948 Treatment of diseases caused by excessive blood vessel growth |
| 06/06/2000 | US6071947 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 06/06/2000 | US6071945 8H-thieno-[2,3-b]pyrrolizin-8-one compounds |
| 06/06/2000 | US6071942 Elevation of circulating blood histamine levels |
| 06/06/2000 | US6071935 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 06/06/2000 | US6071930 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| 06/06/2000 | US6071924 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 06/06/2000 | US6071921 4-phenyl-7-arylquinoazolines; angiogenisis inhibitors and/or vascular permeability reducing effects in warm-blooded animals; anticarcinogenic and -arthritic agents; rheumatic diseases; vascular endothelium growth factor inhibitors |
| 06/06/2000 | US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis |
| 06/06/2000 | US6071914 Comparing the prolactin profile of a mammal to a standard prolactin profile for healthy mammals of the same species and sex and adjusting the prolactin profile of the afflicted mammal to conform to the standard; circadian rhythm rhythms |
| 06/06/2000 | US6071908 Radiation-activated cytotoxin therapy of neoplastic disease |
| 06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
| 06/06/2000 | US6071898 Asiatic acid derivatives having modified A-ring |
| 06/06/2000 | US6071891 Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition |
| 06/06/2000 | US6071885 Administering a cardiac glycosides and aglycone derivatives to inhibit export of leaderless proteins into extracellular spaces; useful in treatment of tumors and diabetes |
| 06/06/2000 | US6071882 Administering an effective synergistic amount of leuteinizing hormone releasing hormone antagonist cetrorelix in combination with alpha-receptor blocking agents to treat the prostate hypertrophy and prostate cancer |
| 06/06/2000 | US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
| 06/06/2000 | US6071721 Calcium binding protein |
| 06/06/2000 | US6071720 Polynucleotide coding a polypeptide associated with ionic mobility; for the diagnosis, treatment or prevention of nervous system disorders, cardiovascular disorders and cancer; anticarcinogenic agents |
| 06/06/2000 | US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery |
| 06/06/2000 | US6071521 Pharmaceutical composition having an antitumor activity and a process for preparation thereof |
| 06/06/2000 | US6071519 Treating autoimmune diseases, hodgkin's disease and other lymph cancers |
| 06/06/2000 | US6071513 Human glutathione-S-transferase |
| 06/06/2000 | US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence |
| 06/02/2000 | WO2000031289A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
| 06/02/2000 | WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors |
| 06/02/2000 | WO2000031263A2 Gtpase associated proteins |
| 06/02/2000 | WO2000031248A1 Humanized monoclonal antibodies |
| 06/02/2000 | WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 06/02/2000 | WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof |
| 06/02/2000 | WO2000031242A2 Engineered cytotoxic ribonuclease |
| 06/02/2000 | WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 06/02/2000 | WO2000031137A1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 06/02/2000 | WO2000031136A1 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 06/02/2000 | WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 06/02/2000 | WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 06/02/2000 | WO2000031100A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031096A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031095A2 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031094A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031093A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031092A2 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031084A1 Prostaglandin conjugates for treating or preventing bone disease |